Drug class
Heparinoid glycosaminoglycan; topical anti-inflammatory and antiexudative agent
Mechanism of action
Mucopolysaccharide polysulfate has local heparinoid, anti-inflammatory, anti-exudative and fibrinolytic properties. The UK product information describes weak inhibition of prostaglandin E2 synthesis, an indirect effect on leukotriene B4, potentiation of urokinase activity and inhibition of hyaluronidase.
General use cases
- Used as a component of topical salicylic acid/mucopolysaccharide polysulfate products for symptomatic relief of muscular pain and stiffness, sprains, strains and pain due to rheumatic and non-serious arthritic conditions. It is not a stand-alone systemic anticoagulant indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
